Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial

BACKGROUND: Cotrimoxazole (CTX) preventive therapy (CPT) reduces opportunistic infections and malaria in HIV-infected patients. In Africa, policies on sustained CPT during antiretroviral therapy (ART) differ between countries. We assessed the safety of discontinuing CPT in stable patients on ART in...

Descripción completa

Detalles Bibliográficos
Autores principales: Anywaine, Zacchaeus, Levin, Jonathan, Kasirye, Ronnie, Lutaakome, Joseph Kayiira, Abaasa, Andrew, Nunn, Andrew, Grosskurth, Heiner, Munderi, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312229/
https://www.ncbi.nlm.nih.gov/pubmed/30596666
http://dx.doi.org/10.1371/journal.pone.0206907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312229/
https://www.ncbi.nlm.nih.gov/pubmed/30596666
http://dx.doi.org/10.1371/journal.pone.0206907

Ejemplares similares